Product
CoVAC-1
1 clinical trial
1 indication
Indication
Primary Immunodeficiency DiseaseClinical trial
B-pVAC-SARS-CoV-2: Phase I/II Multicenter Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults With Bcell/ Antibody DeficiencyStatus: Completed, Estimated PCD: 2022-08-18